Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://ellamnbt241539.ivasdesign.com/60127697/semaglutide-a-potential-solution-for-obesity